FDA Approval Summary: Pemigatinib for Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 fusion or other rearrangement.
暂无分享，去创建一个
Jiang Liu | L. Fashoyin-Aje | Martha Donoghue | R. Pazdur | R. Charlab | M. Theoret | Xinyuan Zhang | Yuching Yang | S. Lemery | Robert N. Schuck | P. Mishra-Kalyani | M. Horiba | S. Chatterjee | Jeanne Fourie Zirkelbach | Yangbing Li | L. Marcus | R. Schuck | Timil H Patel